Rheumatoid Arthritis Patients in Remission Withdrawing from TNF Inhibition Show Flare Increases
New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued TNFi.
United States San Diego Siri Lillegraven South Eastern Norway Regional Health Authority American College Of Rheumatology European Alliance For Associations
Source: hcplive.com